Tomoko Okuyama Selected Research

Tomoko Okuyama Research Topics

Disease

8	Insulin Resistance 01/2023 - 06/2014
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2017
6	Inflammation (Inflammations) 01/2023 - 01/2014
4	Obesity 12/2022 - 06/2014
3	Neoplasms (Cancer) 07/2021 - 06/2014
3	Fatty Liver 10/2020 - 01/2017
2	Hypoglycemia (Reactive Hypoglycemia) 03/2024 - 01/2014
2	Glucose Intolerance 10/2020 - 06/2014
2	Atrophy 10/2020 - 01/2020
2	Hyperinsulinism (Hyperinsulinemia) 06/2014 - 01/2014
2	Headache (Headaches) 01/2014 - 01/2014
1	Endotoxemia 12/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2022
1	Liver Diseases (Liver Disease) 12/2021
1	Hyponatremia 07/2021
1	Meningitis 07/2021
1	Central Nervous System Diseases (CNS Diseases) 07/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Insulinoma 01/2017
1	Lipodystrophy 01/2017
1	Hyperplasia 01/2017
1	Hyperglycemia 06/2014
1	Acute Kidney Injury (Acute Renal Failure) 01/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Unconsciousness (Loss of Consciousness) 01/2014
1	Herpes Zoster 01/2014
1	Nausea 01/2014
1	Choroidal Neovascularization 12/2004

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2016
5	Insulin (Novolin)FDA Link 12/2021 - 01/2014
4	Blood Glucose (Blood Sugar)IBA 03/2024 - 01/2014
4	Insulin ReceptorIBA 10/2022 - 06/2014
4	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 10/2020 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2017
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2020 - 06/2014
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2017
2	AlarminsIBA 12/2022 - 01/2018
2	EnzymesIBA 07/2022 - 01/2020
2	GlucokinaseIBA 01/2016 - 06/2014
1	imegliminIBA 01/2023
1	E2F1 Transcription FactorIBA 10/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 07/2022
1	CalciumIBA 07/2022
1	Uncoupling Protein 2IBA 07/2022
1	HDL CholesterolIBA 12/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021
1	Alanine Transaminase (SGPT)IBA 12/2021
1	XanthineIBA 12/2021
1	Xanthine DehydrogenaseIBA 12/2021
1	Guanosine Triphosphate (GTP)IBA 12/2021
1	SodiumIBA 07/2021
1	Arginine Vasopressin (Argipressin)IBA 07/2021
1	Vasopressins (Vasopressin)IBA 07/2021
1	Tolvaptan FDA Link 07/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2020
1	LinagliptinIBA 10/2020
1	Nonesterified Fatty Acids (NEFA)IBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Complement Factor D (Factor D)IBA 01/2020
1	AdipokinesIBA 01/2020
1	Calcium-Binding ProteinsIBA 01/2018
1	CholesterolIBA 12/2017
1	LDL CholesterolIBA 12/2017
1	Liraglutide FDA Link 12/2017
1	Triglycerides (Triacylglycerol)IBA 12/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Sucrose (Saccharose)IBA 01/2016
1	Linoleic Acid (Linoleate)IBA 01/2016
1	PhlorhizinIBA 06/2014
1	Diazoxide (Hyperstat)FDA Link 01/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2014
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2014
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2014
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2014
1	loxoprofen (CS 600)IBA 01/2014
1	miglitol (Glyset)FDA Link 01/2014
1	Verteporfin (Visudyne)FDA Link 12/2004

Therapy/Procedure

1	Punctures 12/2022
1	Ligation 12/2022
1	Glycemic Control 12/2019
1	Injections 12/2019
1	Therapeutics 12/2019
1	Gastrectomy 01/2014